Author： Bukowski Ronald M
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.8, 2003-08, pp. : 1403-1411
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The antiangiogenic agent AE 941 [`Neovastat'] provides clinical benefit in prostate cancer
Inpharma, Vol. 1, Iss. 1295, 2001-01 ,pp. :
Access to resources
Recommend
By Jang Sekwon Zheng Chaoyi Tsai Huei-Ting Fu Alex Z. Barac Ana Atkins Michael B. Freedman Andrew N. Minasian Lori Potosky Arnold L.
Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. :
By Drevs Joachim Hofmann Inga Marme Dieter Unger Clemens Kratz Felix
Drug Delivery, Vol. 6, Iss. 2, 1999-04 ,pp. :